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Background: The current study was to evaluate the anti-thrombotic effect of alpha-linolenic acid (ALA) which was
isolated and purified from Jiaomu in vivo.
Methods: The seeds were crushed and subsequently subjected to saponification, acid hydrolysis, gradient freezing,
urea inclusion and complexation of silver nitrate to obtain the unsaturated fatty acids. The chemical characteristics
of isolated ALA were validated by 1HNMR, 13CNMR and mass spectrometry, and then the anti-thrombotic effect of
ALA and its mixture with linoleic acid (1:1) were evaluated in the following experiments.
Results: The alpha-linolenic acid was isolated and purified from Jiaomu through our newly established methods.
ALA and its mixture with linoleic acid can prolong the hemorrhage and coagulation time as well as enhanced the
survival rate of mice subjected to collagen-adrenaline induced thrombosis. In addition, the thrombosis on A-V bypass
and platelet aggregation of rats will be reduced after treated with ALA or its mixture, and the expression level of Akt
and PI3K protein decreased 26% and 31%, respectively.
Conclusions: We designed and optimized a very simple and high-yield procedure to isolate ALA and linoleic acid
mixture from seeds of Zanthoxylum bungeanum Maxim and demonstrated that such mixture can obtain a good
anti-thrombotic effect through the modulation of PI3K/Akt signaling.
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fatty acidsBackground
Alpha-linolenic acid (ALA), which belongs to a group of
fatty acids named omega-3 fatty acids, is an essential
fatty acid. Seed oils are the richest sources of ALA, espe-
cially those of rapeseed, soybeans, walnuts, flaxseed, perilla,
chia and hemp. ALA can be obtained from thylakoid mem-
branes of the green leaves of broadleaf plants [1,2]. Similar
to other essential fatty acids, ALA is critical for human bo-
dily function given its conversion into the longer chain fatty
acids eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA). ALA and its metabolic products, has long
been known to reduce the risk of detrimental disorders in-
cluding cardiac arrhythmia, high cholesterolemia, hyperten-
sion, thrombosis, allergy and cancer [3,4]. It was reported
that ALA may possess the anti-arrhythmic properties after* Correspondence: yhxiefmmu@163.com; siwwang@126.com
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unless otherwise stated.investigation of the association between arrhythmia and
dietary ALA intake accessed via updated food-frequency
questionnaires [5]. Intake of omega-3 fatty acids reduces
risk of fatal coronary heart events, perhaps by stabilizing
myocardium and reducing risk of fatal arrhythmias [6]. The
wide variety of ALA-exerted biological actions may have
relevance to their involvements in several physiological and
pathological processes. ALA defect is closely related to the
prevalence of hypertension, diabetes mellitus, coronary
heart disease, schizophrenia, Alzheimer’s disease, athero-
sclerosis and cancer, thus depicting the importance of
adequate intake of ALA in daily life [7-9].
In spite of its crucial role in human health, dietary in-
sufficiency in ALA is a rather common medical problem
worldwide. As such, Food and Agriculture Organization
of the United Nations and World Health Organization
issued a joint statement, urging the necessity of increas-
ing intake of ALA. Its annual demand has been over two
million kilogram. Given ALA synthesis is still beyondd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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natural sources of ALA.
Jiaomu (Semen Zanthozyli bungeani) is the seeds of
Zanthoxylum bungeanum Maxim [10]. In the 1990s,
groups of Chinese scientists discovered that the content of
ALA in Jiaomu is about 17 ~ 24% [11,12], solidifying
Jiaomu as a rich source of ALA. Being seeds of Zanthoxy-
lum bungeanum Maxim, a traditional Chinese cuisine
agent, 120 million kilogram of Jiaomu are discarded in
China each year. As such, Jiaomu could be a rich source
of ALA as long as the obstacles in its chemical production
can be rectified. Up to date, highly efficient procedure is
still lacked for the isolation and purification of ALA.
The aggregation and activation of platelet can affect
the development of myocardial infarction, stroke and
unstable angina, and thus, the anti-platelet agents can be
induced the obviously antithrombotic effect and used to
prevent various cardiovascular disorders. Furthermore, it
has been demonstrated that GP IIb/IIIa receptor which
can regulate the process of hemostasis in the body and
be involved in the thrombus formation and platelet adhe-
sion. The clinical application of platelet glycoprotein IIb/
IIIa (GP IIb/IIIa) antagonists can prevent the fibrinogen-
mediated aggregation of activated platelets [13-15]. But so
far, the detail and further underlying mechanism on the
modulation of anti-thrombotic process was still not clear
after ALA treatment.
In the current study, firstly, we attempted to design
and optimize the chemical strategy in the extraction of
ALA from raw Jiaomu and evaluated its anti-thrombotic
effect in vivo. In addition, the underlying mechanism of
above process was also investigated to evaluate the future
application of Jiaomu in health and dietary areas.
Methods
Materials
Authenticated, quality-certified raw Jiaomu were pur-
chased from the Material Company of Hancheng (Shan’xi
Province, China). Standard ALA compound was obtained
from the Sigma Chemical Company (St Louis, MO, USA).
It was dissolved in normal saline containing 0.5% Tween-
80 prior to use. Aspirin enteric-coated tablet was pur-
chased from Bailu Pharm Co. Ltd., (Xi’an, China). Other
analytical reagents were obtained from the Chemical
Agent Factory of Xi’an (Xi’an, China).
All mice weighing at 18 ~ 22 g and rats weighing at
250 ~ 300 g were provided by the animal center of Fourth
Military Medical University. Animals were housed two
per cage in a room controlled for temperature, lighting
and humidity. All experiments were performed according
to the ethical guidelines on animal care and were approved
by the institutional animal care committee of Fourth
Military Medical University.Preparation of ALA
Acid hydrolyze saponification
The seeds were crushed and sifted out (40 ~ 60 mesh).
The powder was decocted with 5% NaOH for one hour at
65°C and filtrated to obtain the aqua part. Above process
was repeated twice to combine the resulted filtrate. The
solution was treated with H2SO4 (v/v, 1:1) to acidify to
pH 2.0. The oil layer was separated and washed with water
to pH 7.0 to get the mixtures of fatty acid.
Gradient freezing
The mixtures of fatty acid mixed with 95% NaOH (v/v,
1:1) were placed at 0°C for 6 ~ 7 h before filtration. Then
the solution was continuously frozen at −5°C for 6 ~ 8 h,
filtrated and washed off residues with chilled 95% NaOH.
The solvent was distilled-off to obtain the lipid portion.
Urea inclusion
The urea was dissolved into 95% NaOH, and then added
into the frozen mixtures of the fatty acid (oil: urea = 1:1).
After a sufficient mixing, the mixture was subsequently
cooled at 3 ~ 5°C, −6°C and −12°C for 6 ~ 8 h, and then
quickly filtrated. The residue was washed off with 95%
NaOH to obtain the oil after removing the solvent. The
latter was bathed in water for 3 times, extracted with
petrol ether, shaken with dried MgSO4 for 5 ~ 10 min,
and then filtrated. After contraction, the obtained extracts
contained mostly unsaturated fatty acid (50% ALA and
50% linoleic acid).
Complexation of silver nitrate
The mixtures of fatty acids were added into urea, mixed
with AgNO3 solution at low temperature, stirred and
then delaminated. The AgNO3 layer was partitioned in
petrol ether and repeated 2 ~ 3 times. The petrol ether
layers were combined and concentrated to yield ALA.
Chemical analysis
The content of yielded ALA was analyzed by high-
performance liquid chromatography (HPLC; Waters,
Milford) using a C18 column (4.6 × 250 mm; 5 μM) in
90:10 (v/v) acetonitrile/ 1% acetic acid solution delivered
at 1 ml/min as the mobile phase. Elution of compounds
was detected at 205 nm with 2996 UV detector. 1HNMR,
13CNMR and Mass spectrometry measurements were also
performed to validate the produced compound, using
commercial standard ALA compound as the control.
Hemorrhage time and coagulation time determination
All mice were randomly divided into the treated group
with different dosage of ALA, negative (saline) and posi-
tive (aspirin) control groups. ALA treatment groups
were received either pure ALA or its mixture with lino-
leic acid (ALA: linoleic acid = 1:1) at 50, 100, or 250 mg/
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rich plasma (PRP) was prepared and obtained from blood
samples according to the previous methods [16,17]. Brifely,
the sample containing 3.8% sodium citrate were centri-
fuged at 100 × g for 10 min at room temperature to obtain
the PRP in supernatant. After that, the hemorrhage and co-
agulation time were determined by the related Kit (PT and
APTT Kit) and Analyzer (LG-PABER, China).
Thrombus formation analysis
Mice were grouped and treated as described above. After
the last treatment, a mixture of collagen (3.57 mg/kg)
and adrenaline (0.143 mg/kg) were injected into vena
caudal vein of mouse to stimulate thrombus formation
for 5 min through the effect of platelet activation [18].
Mortality was calculated to determine the survival rate.
Artery-venous (A-V) bypass thrombosis and Platelets
aggregation analysis
Rats were randomly divided into the treated and control
groups according to the above procedure. Pure ALA
compound or its mixture with linoleic acid (ALA: lino-
leic acid = 1:1) were administered at 35, 70 or 150 mg/kg
for 10 days. A-V bypass thrombosis analysis was performed
as previously described to determine the wet weight of
thrombus [19].
Venous blood was collected by atraumatic venepuncture
into vacuette tubes containing sodium citrate (3.8%, v/v)
after anesthetized animals. Platelet-rich plasma (PRP) was
prepared according to the above method using collagen I
(22.0 μg/ml) as an inducer. Maximum aggregation rate
and aggregation inhibition rate were determined [20].
Effect of ALA on P-selectin and GP IIb/IIIa expression on
washed platelets
Platelets were prepared as described above. P-selectin
(CD62) and GP IIb/IIIa expression was measured using
FITC-labeled antibody. Briefly [21], platelets were washed
and centrifuged, and then blocked with 5% BSA solution.
The antibody of P-selectin (CD62) and GP IIb/IIIa were
incubated with sample for 30 min at 4°C in the dark,
respectively. Flow cytometry (FCM, Becton Dickinson, San
Jose, CA, USA) was performed to detect the expression of
P-selectin and GP IIb/IIIa.
Western bolt analysis
Western blotting procedure was performed to investi-
gate the changes on related protein expression in the
presence or absence of ALA. Briefly, platelets were pre-
pared as described above. Protein was collected in the
following buffer including 0.1 M NaCl, 0.01 M Tris–HCl
(pH 7.6), 1% (w/v) Triton X-100, 1 mM EDTA (pH 8.0),
100 mg/ml PMSF, 1% (w/v) NP-40, and 1 μg/ml leupep-
tin. After centrifugation at 10,000 × g for 30 min at 4°C,the total protein was harvested and quantified by the BCA
protein assay kit (Pierce, Rockford, IL, USA). After that,
the protein was separated by SDS-PAGE and electrophor-
etically transferred onto a PVDF membrane according to
the standard western blotting protocol. The membrane
was incubated with a primary antibody against PI3K and
Akt (1:1000; Cell Signaling Technology, Beverly, MA, USA)
overnight at 4°C after blocking with 5% milk in PBST. The
enhanced chemiluminescence system was used to detect
the positive belt. The blot was also re-probed and cor-
rected by staining with β-actin antibody (Sigma, St Louis,
MO, USA).
Statistical analysis
Data are presented as means ± SD. Differences between
groups were evaluated by the student’s t test. ANOVA
was applied to examine the difference in survival rate.
All analyses were performed utilizing the SPSS software
package (Version 11.5, SPSS Inc., Chicago, IL). Differ-
ences were considered statistically significant at p < 0.05.
Results
Chemical characteristics
The characteristics of isolated and purified alpha-linolenic
acid (ALA) from Jiaomu were evaluated through the fol-
lowing experiments. A Quattro Premier MS system (Wa-
ters Corp., Milford, MA, USA) operating under Masslynx
4.1 software was performed using liquid chromatog-
raphy/electrospray ionization tandem mass spectrom-
etry equipped with an electrospray ionization interface
used to generate positive ions [M−H+] for the determin-
ation of ALA. The positive ion mass spectra of ALA
showed stable molecular ions at m/z = 279.6 (Figure 1b).
The source temperature was 110°C. The electrospray
capillary voltage was 3.0 kV, nitrogen was the desolva-
tion gas (500 mL/min flow rate). Compounds were sep-
arated on a reversed-phase column by a Waters 2695
HPLC system. The column temperature was 25°C. The
retention time of isolated ALA sample was 6.036 min,
identical to that of the standard compound (Figure 1d).
The purity of ALA ranged from 91.6% to 95.2%. NMR
analysis data were presented as follows: 13CNMR δ/
ppm (Figure 2a): 180.43 (C1), 134.13 (C2), 131.85 (C9),
130.14 (C16), 128.26 (C12), 128.22 (C13), 127.80 (C15),
127.16 (C10), 29.62 (C6), 29.21 (C7), 29.13 (C5), 29.09
(C4), 27.23 (C8), 25.65 (C14), 25.56 (C11), 24.69 (C3),
20.56 (C17), 14.26 (C18);
1HNMR δ/ppm (Figure 2b):
11.4 (br, s, 1H, −COOH), 5.3 ~ 5.4 (m, 6H, −CH-CH-,
C9, 10, 12, 13, 15, 16), 2.8 (t, 4H, CH2, CH2, C11, 14), 2.35
(t, 2H, CH2, C2), 2.06 (m, 4H, CH2, C8, 17), 1.63 (m,
2H, CH2, C3), 1.32 (m, 8H, CH2, C4, 5, 6, 7), 0.98 (t, 3H,
CH3, C18). And above data also provided the certainly
evidence for efficiently isolated and purified methods of
ALA from Jiaomu.
Figure 1 Chemical characteristics of alpha-linolenic acid. (a) Chemical structure of alpha-linolenic acid; (b) Negative ion mass spectra of
alpha-linolenic acid, m/z = 279.6; (c) UV; (d) HPLC.
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To explore the effect of ALA on the stanching and coagula-
tion functions of mice, we examined the hemorrhage and
coagulation time of ALA or its mixture treated mice. As
shown in Figure 3a or b, pure ALA with lower, middle or
higher dosage (50, 100 or 250 mg/kg) prolonged the
hemorrhage and coagulation time, respectively. The mix-
ture composed of ALA and linoleic acid (1:1) also remark-
ably increased hemorrhage and coagulation time. For above
positive effects on hemorrhage time, there is no clear differ-
ence among each treated groups, but for coagulation time,
the effects displayed with a concentration-dependent man-
ner both in pure and mixture treated groups. In the group
of mixture with higher dosage, the coagulation time
increased at least 35% compared with the saline treated
group. Our results indicated that both ALA and the
mixture treatment significantly inhibited blood standing
and coagulation in mice.Effects of ALA on thrombosis
We further determined the therapeutic effect of ALA and
its mixture on stimulate thrombosis formation. Collagen
and adrenaline efficiently induced thrombus formation in
mice, as revealed by rapid mortality of most animals
following the inducer treatment. Similar to aspirin, ALA
enhanced the survival rate of the animals significantly
(Figure 3c). After treated with 250 mg/kg ALA, the sur-
vival rate increased at least 3.5 times compared with saline
treated group, indicating that ALA can completely inhibit
collagen- and adrenaline-induced thrombosis in mice at
this concentration. And for the mixture treated group
with higher dosage, the similar effects were also observed
and no difference between these two groups.After treated with ALA or its mixture in rats, A-V by-
pass thrombosis was also evaluated in each group. Like-
wise, ALA and its mixture were found to inhibit collagen
stimulated A-V bypass thrombosis in rats. Both pure ALA
and mixture with lower, middle or high dosage (35, 70 or
175 mg/kg) suppressed A-V thrombus formation, respect-
ively. Compared with saline treated group, the thrombotic
wet weight decreased 33% and 42% after treated with
ALA or its mixture group, respectively (Figure 3d). Our
above results indicated that the ALA mixture offered a
better therapeutic effect than the pure ALA compound.
Effects of ALA on collagen-induced platelet aggregation in
rats
Moreover, we explored the effect of ALA and its mixture
on the collagen-induced platelet aggregation (Figure 3e).
Firstly, the effect of aspirin (100 mg/kg) on the inhibition
of collagen stimulated platelet aggregation was observed
in vitro. After treated with middle or high dosage (70 or
175 mg/kg) pure ALA, such inhibition was also occurred
obviously, the platelet aggregation decreased 29% or 34%
in middle or higher dosage group, respectively. But for
lower dosage (35 mg/kg) group, there was no significant
changes compared with saline treated group. Similar
results were also observed after treated with ALA mixture,
the platelet aggregation decreased 39% or 46% in middle
or high dosage group, respectively.
Effect of ALA on P-selectin and GP IIb/IIIa expression
The effects on platelet P-selectin and GP IIb/IIIa expres-
sion were examined by FCM after treated with pure ALA
or its mixture. As shown in Figure 4a, ALA reduced
P-selectin secretion at 12%, 27% or 32% in the different
group with lower, middle or higher dosage, respectively.
Figure 2 NMR analysis data of alpha-linolenic acid. (a) 1HNMR δ/ppm; (b) 13CNMR δ/ppm.
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Figure 3 Anti-thrombotic effects of alpha-linolenic acid. (a) Effects of ALA on hemorrhage time; (b) Effects of ALA on coagulation time; (c)
Effect of ALA on trombus formation analysis, mortality was calculated to determine the survival rate; (d) Effect of ALA on artery-venous (A-V) bypass
thrombosis, the wet weight of thrombus was determined by subtracting the weight of dry cotton thread; (e) Rat platelets were isolated and platelet
aggregation was determined in vitro. Aspirin (100 mg/kg), α-LNA 1–3 (pure ALA: 50, 100 and 250 mg/kg), α-LNA 4–6 (ALA mixture: 50, 100 and
250 mg/kg), * p < 0.05, ** p < 0.01 vs. control group.
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36% or 41%, respectively. In addition, the expression of
GP IIb/IIIa decreased 25%, 31% or 35% in ALA treated
group with lower, middle or higher dosage, respectively.
Similar tendency on GPIIb-IIIa expression were observed
after ALA mixture treatment, it decreased 24%, 38% or
45%, respectively (Figure 4b).Figure 4 Effect of ALA on P-selectin, GP IIb/IIIa expression and PI3K s
(* p < 0.05, ** p < 0.01 vs. control group.); (c) western blot results showed th
100 and 250 mg/kg), α-LNA 4–6 (ALA mixture: 50, 100 and 250 mg/kg).Effect of ALA on PI3K signaling
The expression level of Akt and PI3K, which are directly
related to changes in thrombosis formation process, were
examined after ALA and its mixture treatment through
western blot analysis. The results showed that Akt expres-
sion decreased 26% in ALA treated group, and 35% in
ALA mixture treated group, respectively. After treatedignaling. Effect of ALA on P-selectin (a) and GP IIb/IIIa (b) expression
e effect of ALA on PI3K and AKT expression. α-LNA 1–3 (pure ALA: 50,
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thermore, the expression of PI3K were also decreased 31%
and 39% after treated with ALA and its mixture, respect-
ively (Figure 4). Above results provided the direct evidence
that both ALA and its mixture have the obvious anti-
thrombosis effects which were related to the changes of
PI3K or Akt protein expression level, and such effects of
ALA on the protein changes was similar with ALA mixture
treated group, which was the possible reason for the above
similar tendency on anti-thrombosis effects between ALA
and its mixture.
Discussion
In the current study, our data provided the following
evidences: (1) the highly purified ALA was isolated from
Jiaomu through our newly established methods; (2) ALA
and its mixture can reduce the thrombosis on A-V bypass
and platelet aggregation; (3) The hemorrhage and coagula-
tion time can be prolonged after treated with ALA and its
mixture with linoleic acid; (4) ALA and its mixture appli-
cation can reduce the P-selectin secretion and GPIIb-IIIa
expression; (5) Anti-thrombotic effect of ALA was related
to the expression of PI3K and Akt, which may be the pos-
sible mechanism of above process. And thus, above data
demonstrate that ALA can affect the process of throm-
botic through the modulation of PI3K/Akt signaling.
We designed and optimized the isolation procedure of
ALA from Jiaomu, seeds of Zanthoxylum bungeanum
Maxim, and demonstrated an important role of these
seeds as a potential source of ALA. Given that most fatty
acids exist along with lipid, we attempted to extract the
fatty acid mixture by acid leaching following decoction
in 5% NaOH. Our current approach was revealed to be
more efficient than the traditional method in separating
lipids from raw materials. Moreover, our method is more
feasible for industrial production. Based on the various
freezing points of fatty acids, we applied the gradient
freezing method to facilitate removal of wax, saturated
fatty acids, mono- and di-unsaturated fatty acids which
should help to reduce consumption of urea and enhance
its efficiency. As previously reported [22], urea can form
stable inclusion with saturated and mono-unsaturated fatty
acids at low temperature, which results in isolate poly-
unsaturated fatty acids. Since urea also form inclusion with
some of unsaturated fatty acids, it is crucial to maintain
proper urea content in order to prevent the loss of ALA.
It was demonstrated that the function of blood stanch-
ing and coagulation can be represented through the evalu-
ation on hemorrhage and coagulation time. According to
our results, ALA treatment prolonged both indices in
mice, consistent with the results from previously report
[23]. Furthermore, ALA isolated from the seeds can greatly
enhance the survival rate of mice suffering from collagen/
adrenaline-induced thrombosis and decrease the mass ofthrombus formed during A-V bypass. All these data col-
lectively confirmed the in vivo activity of extracted ALA
and thus demonstrated that the isolation procedure re-
ported in our study not only increases the yield but also
successfully maintains the biological activity of the com-
pound of interest.
It has been evidenced that the process of platelet aggrega-
tion and thrombus formation was related to the P-selectin
secretion and GP IIb/IIIa activation which was also cross-
linked Akt activation [24,25]. Our current results provided
the certainly evidence that ALA can reduce P-selectin
secretion and GP IIb/IIIa expression obviously. Further-
more, the platelet function, including activation, adhesion,
spreading, and aggregation, was related to the changes on
the signaling pathway of PI3K and Akt which was the main
target of PI3K [26,27]. Our results also showed that ALA
reduced the expression level of PI3K and Akt. And such
results demonstrated that the anti-thrombotic effect of
ALA will be related to the PI3K signaling pathway.
In our current study, it was interested to find that the
biological activity of ALA and linoleic acid (1:1) mixture
is superior to that of the pure ALA. We speculated that
it may be ascribed to the competition of linoleic acid
with ALA in metabolism. Although the two acids have
their specific metabolic pathways, they share the similar
enzymes. ALA is metabolized into EPA and DHA by the
action of a serious of desaturase and elongase, while
linoleic acid is converted to arachidonic acid (AA). The
competition between ALA and linoleic acid suppresses
the production of AA, which competes with EPA for cy-
clooxygenase and lipooxidase and consequently inhibits the
generation of leukotrienes and prostaglandins. According
to our results, ALA and linoleic acid mixture at 1:1 can
achieve a better anti-thrombosis efficiency than ALA alone,
suggested that their relative ratio is crucial for the ultimate
therapeutic effect. Notably, the urea inclusion method ap-
plied in the current study yielded the mixture, consisting of
50% ALA and 50% linoleic acid. The extracts from Jiaomu
through urea inclusion cannot only achieve favorable
therapeutic effect, but also greatly simplify the production
procedure and costs.
Conclusions
In summary, we designed and optimized a very simple
and high-yield procedure to isolate ALA and linoleic acid
mixture from seeds of Zanthoxylum bungeanum Maxim.
The data demonstrated that such mixture can achieve a
better anti-thrombosis effect than pure ALA through the
modulation of PI3K/Akt signaling. Our results favor the
seeds as a rich source of ALA and consolidate its future
application in dietary and medical areas.
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